No matter how cynical the overall market is, Viking Therapeutics Inc (VKTX) performance over the last week is recorded 0.49%

A new trading day began on Friday, with Viking Therapeutics Inc (NASDAQ: VKTX) stock price up 4.30% from the previous day of trading, before settling in for the closing price of $41.12. VKTX’s price has ranged from $17.23 to $99.41 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Meanwhile, its annual earnings per share averaged -4.64%. With a float of $108.05 million, this company’s outstanding shares have now reached $111.43 million.

Let’s determine the extent of company efficiency that accounts for 27 employees. In terms of profitability, gross margin is 28.9%, operating margin of -30726.61%, and the pretax margin is -22741.06%.

Viking Therapeutics Inc (VKTX) Breakdown of a Key Holders of the stock

As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Viking Therapeutics Inc is 3.04%, while institutional ownership is 73.78%. The most recent insider transaction that took place on Nov 08 ’24, was worth 137,333. In this transaction Director of this company sold 2,000 shares at a rate of $68.67, taking the stock ownership to the 47,965 shares. Before that another transaction happened on Nov 08 ’24, when Company’s Director proposed sale 2,000 for $68.67, making the entire transaction worth $137,333.

Viking Therapeutics Inc (VKTX) Recent Fiscal highlights

According to the Wall Street analysts, stocks earnings will be around -4.64% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 40.00% during the next five years compared to -18.89% drop over the previous five years of trading.

Viking Therapeutics Inc (NASDAQ: VKTX) Trading Performance Indicators

Here are Viking Therapeutics Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 36.47.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.94, a number that is poised to hit -0.27 in the next quarter and is forecasted to reach -1.49 in one year’s time.

Technical Analysis of Viking Therapeutics Inc (VKTX)

Looking closely at Viking Therapeutics Inc (NASDAQ: VKTX), its last 5-days average volume was 2.3 million, which is a jump from its year-to-date volume of 1.74 million. As of the previous 9 days, the stock’s Stochastic %D was 44.86%. Additionally, its Average True Range was 2.64.

During the past 100 days, Viking Therapeutics Inc’s (VKTX) raw stochastic average was set at 11.59%, which indicates a significant decrease from 47.35% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 95.57% in the past 14 days, which was higher than the 79.95% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $54.06, while its 200-day Moving Average is $60.72. However, in the short run, Viking Therapeutics Inc’s stock first resistance to watch stands at $43.51. Second resistance stands at $44.14. The third major resistance level sits at $45.32. If the price goes on to break the first support level at $41.70, it is likely to go to the next support level at $40.52. Now, if the price goes above the second support level, the third support stands at $39.89.

Viking Therapeutics Inc (NASDAQ: VKTX) Key Stats

With a market capitalization of 4.99 billion, the company has a total of 111,436K Shares Outstanding. Currently, annual sales are 0 K while annual income is -85,900 K. The company’s previous quarter sales were 0 K while its latest quarter income was -24,940 K.